Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Novel chemotherapeutic agent FX-9 activates NF-κB signaling and induces G1 phase arrest by activating CDKN1A in a human prostate cancer cell line

Fig. 2

DEGs belonging to Reactome pathways “Immune System”, and “Cell Cycle” after 6-h and 12-h FX-9 exposure. Numbers given for each gene display the FC (in linear space) of 6-h and 12-h samples versus the control. Values highlighted in red or blue indicate significantly higher or lower expression. Non-highlighted values are not significantly different (LIMMA p-value < 0.05, and FDR-value < 0.05)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us